Bio-Rad Laboratories Total Assets 2010-2022 | BIO.B

Bio-Rad Laboratories total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bio-Rad Laboratories total assets for the quarter ending March 31, 2022 were $14.374B, a 3.16% increase year-over-year.
  • Bio-Rad Laboratories total assets for 2021 were $17.776B, a 37.03% increase from 2020.
  • Bio-Rad Laboratories total assets for 2020 were $12.973B, a 61.98% increase from 2019.
  • Bio-Rad Laboratories total assets for 2019 were $8.009B, a 42.73% increase from 2018.
Bio-Rad Laboratories Annual Total Assets
(Millions of US $)
2021 $17,776
2020 $12,973
2019 $8,009
2018 $5,611
2017 $4,273
2016 $3,851
2015 $3,710
2014 $3,341
2013 $3,389
2012 $3,444
2011 $3,097
2010 $3,063
2009 $2,536
Bio-Rad Laboratories Quarterly Total Assets
(Millions of US $)
2022-03-31 $14,374
2021-12-31 $17,776
2021-09-30 $19,953
2021-06-30 $15,118
2021-03-31 $13,933
2020-12-31 $12,973
2020-09-30 $12,021
2020-06-30 $10,097
2020-03-31 $8,684
2019-12-31 $8,009
2019-09-30 $7,177
2019-06-30 $7,647
2019-03-31 $6,863
2018-12-31 $5,611
2018-09-30 $6,719
2018-06-30 $6,386
2018-03-31 $6,215
2017-12-31 $4,273
2017-09-30 $4,186
2017-06-30 $4,143
2017-03-31 $3,953
2016-12-31 $3,851
2016-09-30 $4,020
2016-06-30 $3,875
2016-03-31 $3,753
2015-12-31 $3,710
2015-09-30 $3,666
2015-06-30 $3,525
2015-03-31 $3,326
2014-12-31 $3,341
2014-09-30 $3,386
2014-06-30 $3,468
2014-03-31 $3,441
2013-12-31 $3,389
2013-09-30 $3,280
2013-06-30 $3,483
2013-03-31 $3,457
2012-12-31 $3,444
2012-09-30 $3,303
2012-06-30 $3,169
2012-03-31 $3,188
2011-12-31 $3,097
2011-09-30 $2,970
2011-06-30 $3,044
2011-03-31 $2,909
2010-12-31 $3,063
2010-09-30 $2,682
2010-06-30 $2,527
2010-03-31 $2,547
2009-12-31 $2,536
2009-09-30 $2,478
2009-06-30 $2,344
2009-03-31 $1,955
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.121B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $164.449B 10.01
QIAGEN (QGEN) Netherlands $10.298B 16.25
Biohaven Pharmaceutical Holding (BHVN) United States $10.114B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.068B 0.00
Emergent Biosolutions (EBS) United States $1.695B 7.26
Arcus Biosciences (RCUS) United States $1.307B 33.13
Myovant Sciences (MYOV) United Kingdom $0.933B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.493B 0.00
Gelesis Holdings (GLS) United States $0.348B 0.00
Zymeworks (ZYME) Canada $0.342B 0.00
Ambrx Biopharma (AMAM) United States $0.162B 0.00
Enzo Biochem (ENZ) United States $0.112B 23.00
SQZ Biotechnologies (SQZ) United States $0.094B 0.00